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Abstract
Background: The emergence of methicillin-resistant Staphylococcus aureus (MRSA) is a main concern in burn care
centers worldwide. The some reports of MRSA in Iran suggested that MRSA with type SCCmec III is common
among burn patients. The aim of this study was to determine the prevalence, virulence genes, and antimicrobial
susceptibility of the direct repeat units (dru) types of MRSA with SCCmec IIIA isolated from burn wounds in a burn
care center in Tehran, Iran.
Methods: In total, 165 S. aureus isolates were collected from clinical samples. In order to detect MRSA isolates, the
mecA gene was amplified through the polymerase chain reaction (PCR) method. Antimicrobial susceptibility was
tested using the disc agar diffusion test. Moreover, the PCR method was applied to determine SCCmec types,
virulence genes, and antimicrobial resistance genes. The dru region was sequenced and thereby, dru types and dru
repeats were identified. A similarity matrix was used to create minimum spanning tree (MST).
Results: The prevalence of MRSA was 69% (114 out of 165 isolates). Most of MRSA isolates (61 out of 114, 53.5%)
were SCCmec type IIIA. All MRSA isolates were vancomycin-susceptible and more than 68% of MRSA isolates with
SCCmec type IIIA were mupirocin resistant. The successful dru typing of isolates with SCCmec type IIIA revealed
fourteen different dru types. There were two new dru types, namely dt10di and dt7aj. MST analysis indicated the
presence of the three clusters of dt10di (cluster I), dt8i-dt8 h (cluster II), and dt11c-dt10ao-dt11dd-dt11a-dt10a
(cluster III). There were significant differences between clusters I and II respecting antimicrobial resistance pattern
and virulence genes.
Conclusion: Three main dru clusters are prevalent in the study setting. The main dru types in the setting are dt10di,
dt8i, and dt8 h. Dru typing can be used to differentiate MRSA strains with SCCmec IIIA.
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Background
Staphylococcus aureus (S. aureus) is one of the most
common causes of infection among patients with severe
burn wounds [1, 2]. Colonization of burn wounds with
S. aureus can cause septicemia and substantially in-
crease mortality rate [3]. The pathogenicity of S. aureus
strains depends on different virulence factors such as
Panton-Valentine leukocidin (PVL), staphylococcal en-
terotoxins, and hemolysins alpha, beta, gamma, and
delta [4].
One of the major concerns in the treatment of infec-
tions is antimicrobial resistance, particularly to methicil-
lin [5, 6]. Methicillin resistance is encoded by the mecA
gene. In 2011, a second gene, mecC has been discovered
that also causes methicillin/beta-lactam resistance. Both
genes are situated on large, potentially mobile genetic el-
ements, so-called SCCmec elements (staphylococcal cas-
sette chromosome mec) [7, 8]. So far, thirteen main
types of SCCmec have been identified [9]. These types
differ from each other in size and genetic composition.
Some studies reported that MRSA with SCCmec III is
the most prevalent type of S. aureus in burn care centers
in some countries of the world [2, 10–12]. The few re-
ports of MRSA in Iran also suggested that MRSA with
type SCCmec III is common among burn patients [13,
14]. mecC MRSA represent a recently recognised form
of MRSA, encoding a divergent mec gene, which can
colonise and cause disease in humans and a wide range
of other host species [8].
A variable number of tandem repeats region including
40-bp of direct repeat units (dru) has been detected
downstream to the mecA gene close to IS431 in the
SCCmec element. The sequencing of this region can be
used for detecting and subtyping methicillin-resistant S.
aureus (MRSA) [15, 16]. A study reported that the dru
typing of ST239 MRSA isolates provided the clearest
distinction between SCCmec IIIA and III isolates [17].
Dru types are stable enough and hence, can be used in
epidemiological analyses [16, 18].
Despite the high prevalence of MRSA with SCCmec III
in burn care centers, there is limited information about
its dru types. Therefore, the present study was con-
ducted in a burn care center in Tehran, Iran, to deter-
mine the prevalence, virulence genes, and antimicrobial
susceptibility of the dru types of MRSA with SCCmec
IIIA isolated from burn wounds.
Materials and methods
Bacterial isolates
In total, 165 non-duplicate S. aureus isolates were col-
lected using sterile swab from burn wound infections in
a burn care center in Tehran, Iran. Sampling was done
in four consecutive trimesters from June 2013 to June
2014. Isolates were primarily identified as S. aureus
based on colony morphology, Gram staining, and cata-
lase, coagulase, mannitol fermentation, and deoxyribo-
nuclease tests [19]. Then, the identity of S. aureus
isolates was confirmed through the amplification of the
femA gene based on the polymerase chain reaction
(PCR) method and using primers explained in an earlier
work [20]. After that, in order to identify MRSA isolates,
the mecA gene was detected using specific primers [21,
22]. Finally, MRSA isolates were subjected to further
testing.
Antimicrobial susceptibility tests
The antimicrobial susceptibility of MRSA isolates was
tested via the disc diffusion method on Mueller-Hinton
agar based on the guideline recommended by the Clinical
and Laboratory Standards Institute (CLSI) [23]. The discs
used in this study were cotrimoxazole 25 μg, erythromycin
15 μg, clindamycin 2 μg, mupirocin 5 μg, rifampin 5 μg, li-
nezolid 30 μg, and quinupristin-dalfopristin 15 μg (MAST,
Merseyside, England). The microbroth dilution method
was also used to determine the antimicrobial minimum
inhibitory concentration (MIC) of oxacillin and vanco-
mycin (Sigma, Steinheim, Germany). The control strain
was S. aureus ATCC 29213. Moreover, the PCR method
was employed to amplify the ermA, ermC, blaZ, and
mupA genes using specific primers [24].
SCCmec typing and detection of virulence genes
SCCmec types were determined through the Multiplex-PCR
as described elsewhere [21, 25]. The PCR method was used
to detect the genes encoding haemolysins (hla, hlb), toxic
shock syndrome toxin (tst), exfoliative toxin A (eta),
staphylococcal enterotoxins (sea, seb and sec), and Panton–
Valentine leukocidin (pvl) among isolates with SCCmec type
III [22, 26, 27].
Dru typing
Dru region was detected using the primers HVR1:59
ACTATTCCCTCAGGCGTCC 39 and HVR2:59 GGAG
TTAATCTACGTCTCATC 39 [28]. The sequencing of
all PCR products was performed on both strands
through the same primers used in the primary PCR. The
ChromasPro software (Technelysium Pty, Australia) was
employed to analyze and align sequences. New repeats
were confirmed through re-sequencing. Then, the no-
menclature published by Goering et al. [16] (available at
www.dru-typing.org) was used to detect and name dru
repeats (dr, 40 bps) and dru types (dt, the combination
of dru repeats). A minimum spanning tree (MST) was
also created via the BioNumerics software v. 7.6.1 (Ap-
plied Maths, Austin, USA) and distance intervals were
created using a bin distance of 1.0%. Clustering was
done based on the distances among dru types. Accord-
ingly, dru types, separated by a single MST distance,
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were considered to be closely related to each other and
hence, were assigned to an identical cluster.
Data analysis
Data were presented using the measures of descriptive
statistics. Moreover, the Fisher’s exact test was con-
ducted for categorical comparisons. The level of signifi-
cance was set at less than 0.05.
Results
Among 165 S. aureus isolates, 114 (69%) were MRSA.
Most of MRSA isolates (61/114; 53.5%) were SCCmec
type IIIA. Also, twenty (17.5%) were identified as
SCCmec type V, two (1.7%) as SCCmec type I, and 31
(27.2%) as non-typable.
All MRSA isolates showed susceptibility to vanco-
mycin (MIC50 ≤ 1 μg/ml, MIC90 ≤ 2 μg/ml), while most
MRSA isolates (68%) were resistant to mupirocin.
All MRSA isolates were resistant to cefoxitin and more
than 73% of them were resistant to erythromycin and clin-
damycin. Moreover, around 53% of MRSA isolates were re-
sistant to mupirocin and trimethoprim-sulfamethoxazole.
However, only a few of MRSA isolates showed resistance to
rifampin (22%), quinupristin/dalfopristin (2%), and linezolid
(2%). The MIC of oxacillin in 100% of MRSA isolates was
higher than 64 μg/mL and all of isolates were susceptible to
vancomycin. The most prevalent antimicrobial resistance
gene was blaZ which was found in 85% of isolates followed
by ermA, mup and ermC which were found in 65, 64 and
57% of isolates, respectively. The most prevalent genes en-
coding virulence factors in MRSA isolates were hla (61%),
hlb (44%), sea (23%) and seb (2%), respectively. The sec, eta,
tst, and pvl genes were not detected in any of MRSA iso-
lates in this study.
As Table 1 shows, all dru types of SCCmec type III
were successfully identified, which included fourteen dif-
ferent dru types with fifteen dru repeats. Among the
identified dru types, two were new (dt10di and dt7aj).
The most prevalent dru types among SCCmec type IIIA
isolates were dt10di, dt8 h, and dt8i. Each minor dru
type was observed only in one isolate.
MST analysis revealed three clusters of SCCmec type
IIIA, namely dt10di (cluster I), dt8i-dt8 h (cluster II), and
dt11c-dt10ao-dt11dd-dt11a-dt10a (cluster III) (Fig. 1).
Analysis of dru types indicated that cluster I was the most
prevalent dru cluster in the first nine months of the study
(i.e. from June 2013 to February 2014), while cluster II
was the most prevalent cluster in the last trimester of the
study (i.e. from March to May 2014) (Table 1).
The results of antimicrobial susceptibility tests on clus-
ters I and II indicated that resistance to rifampin in cluster
II was significantly higher than cluster I (P = 0.003). More-
over, the results of virulence gene analysis illustrated the
significantly higher prevalence of the virulence gene hlb in
cluster II compared with cluster I (P = 0.01).
Analysis of antimicrobial susceptibility pattern indi-
cated that 92% of isolates in cluster I were resistant to
erythromycin, clindamycin, cotrimoxazole, and mupiro-
cin. On the other hand, 44% of isolates in cluster II
showed resistance to erythromycin, clindamycin, cotri-
moxazole, rifampin, and mupirocin.
Analysis of the patterns of antimicrobial resistance
gene also showed that the most prevalent patterns in
clusters I and II were ermA + ermC + blaZ +mup and
ermA + ermC + blaZ, respectively. Moreover, the greatest
frequency of virulence gene patterns in these two clus-
ters was respectively related to hla + sea and hla + hlb.
However, the sec, eta, tst, and pvl genes were detected in
none of the MRSA isolates.
Discussion
This study aimed to determine the prevalence, virulence
genes, and antimicrobial susceptibility of the dru types
of MRSA with SCCmec III isolated from burn wounds
in a burn care center in Tehran, Iran. Study results illus-
trated that the prevalence of MRSA among patients with
burn wounds was 69%. This prevalence rate is higher
than the rates reported in earlier studies in Iran [20, 29,
30], except for a study in burn centers in Ahvaz which
reported a prevalence rate of 80% [31]. Moreover, the
prevalence of MRSA in the present study was higher
than the rates reported in burn centers in the United
States (32%), European countries (26%), and Australia
(23%) [32–34]. This difference can be attributed to the
differences in infection control policies used in different
areas.
Our study also showed that a high proportion of
MRSA isolates harbored SCCmec type IIIA. Similarly,
studies in Iran and other Asian countries reported the
high prevalence of SCCmec type IIIA [13, 35–37].
SCCmec types III and IIIA were also detected in Hun-
garian and Brazilian clones [36]. MRSA isolates with
SCCmec types III can act as large reservoirs of entero-
toxins and antimicrobial resistance and prevail in com-
munities. Our previous survey shown that the sea, hla,
fib and icaA were most frequent genes encoding viru-
lence factors among MRSA with SCCmec type IIIA [4].
Therefore, accurate diagnosis and effective control strat-
egies are essential to minimize their prevalence. Other-
wise, they may become prevalent and cause serious
consequences in a near future.
None of the MRSA isolates in the present study were
resistant to vancomycin. Although MRSA non-resistance
to vancomycin in our study supports the effectiveness of
this antibiotic in managing MRSA, this antibiotic should
be prescribed with great caution in order to prevent the
emergence of vancomycin-resistant S. aureus.
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Table 1 Antimicrobial resistance pattern, antibiotic resistance genes, virulence genes, and dru types in MRSA isolates with type III
SCCmec
Sampling Time Sample no. Dru type Cluster Antibiotic resistance Antibiotic resistance genes Virulence genes
First trimester 1 10di I E, CD, TS, MUP ermA, ermC, blaZ sea
2 10di I E, CD, TS, MUP ermC, blaZ hla, sea
3 11dd III E, CD, TS, SYN, MUP ermA, mup hla, hlb
4 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup –
5 7aj – E, CD, TS, MUP ermA, ermC, blaZ hla, sea
6 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, sea
7 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, sea
8 14 k – E, CD, TS, MUP ermC, blaZ sea
9 11c III E, CD, TS, MUP ermA, ermC, blaZ, mup –
10 10di I E, CD, TS, MUP ermA, ermC, blaZ hla, hlb, seb
11 10di I E, CD, TS, MUP ermA, ermC, blaZ hla, seb
12 11a III E, TS, MUP blaZ, mup –
13 5 k – E, CD, TS, MUP ermA, ermC, blaZ, mup –
14 10di I E, CD, TS, MUP ermA, blaZ, mup sea
15 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, sea
16 10di I E, CD, TS, MUP ermA, ermC, blaZ –
17 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, sea
Second trimester 18 10di I E, CD, TS, MUP ermC –
19 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup –
20 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, sea
21 10di I E, CD, TS, MUP blaZ sea
22 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, sea
23 10di I E, CD, TS, MUP ermA, ermC, mup hla, sea
24 10di I E, CD, TS, MUP ermC, blaZ hla, sea
25 10di I E, CD, TS, MUP ermA, blaZ Sea, seb
26 10ao III E, CD, MUP ermA, ermC, mup –
27 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, hlb, sea
28 10di I SYN, MUP ermC, blaZ, mup sea
29 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, sea
30 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla
31 10di I E, CD, TS, MUP ermA, ermC, blaZ sea
32 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, sea
33 8af – E, CD, RP, MUP ermC, blaZ, mup –
34 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, sea
Third trimester 35 10di I E, CD, TS, MUP ermC, blaZ –
36 10di I E, CD, TS, MUP ermA, ermC, mup –
37 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, sea
38 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, hlb, sea
39 10di I E, CD, TS, MUP ermA, ermC, blaZ hla, hlb, sea
40 10a III MUP ermA, ermC, blaZ, mup hla
41 10di I E, CD, TS, MUP ermC, blaZ, mup seb
42 10di I E, CD, TS, SYN, LZD, RP, MUP ermA, ermC, blaZ, mup –
43 10di I E, CD, TS, MUP ermA, ermC sea
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Table 1 Antimicrobial resistance pattern, antibiotic resistance genes, virulence genes, and dru types in MRSA isolates with type III
SCCmec (Continued)
Sampling Time Sample no. Dru type Cluster Antibiotic resistance Antibiotic resistance genes Virulence genes
44 10di I E, CD, TS, MUP ermA, ermC –
45 10di I E, CD, TS ermA, ermC, blaZ, mup hla, hlb
46 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup hla, sea
47 10di I E, CD, TS, MUP ermA, ermC, blaZ hla, sea
48 10di I E, CD, TS, MUP mup –
49 10c – E blaZ sea
Forth trimester 50 8i II E, TS, MUP ermA, ermC, blaZ, mup hla, hlb
51 8 h II – blaZ, mup hla
52 6d – – ermA, blaZ, mup hla, hlb
53 8i II CD ermA, ermC, mup hla, hlb
54 8i II E, CD, TS, MUP ermA, ermC, blaZ hla, hlb, sea
55 8 h II E, TS, RP, MUP blaZ hlb, sea
56 8 h II E, CD, TS, RP, MUP ermA, ermC, blaZ, mup sea
57 8 h II E, CD, TS, RP, MUP ermC –
58 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup –
59 8i II E, CD, TS, RP, MUP ermA, ermC, blaZ hla, hlb
60 10di I E, CD, TS, MUP ermA, ermC, blaZ, mup –
61 8 h II E, CD, TS, RP, MUP ermC –
FOX: Cefoxitin, E: Erythromycin, CD: Clindamycin, TS: trimethoprim/ Sulfamethoxazole, RP: Rifampicin,
SYN: quinupristin/dalfopristin, LZD: Linezolid, MUP: Mupirocin
Fig. 1 Minimum Spanning Tree generated using the BioNumerics software representing the fourteen dru types and the fifteen dru repeats
observed in the studied isolates. Numerical values on the branches indicate the similarities (MST distance) between different dru types.
BioNumerics software created similarity values (termed bins) and converted these values into distance units. The bin unit distance was set at 1%
(i.e., dru types at a distance of 1 on the MST had a similarity of more than 99%, while dru types at a distance of 2 had a similarity of 98–99%, and
so on). Dru types were assigned to the same cluster (depicted in color) if they were separated by an MST distance of 1 (i.e. if they showed a
similarity of at least 99%)
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The prevalence of MRSA resistance to mupirocin in
the present study was 68%. However, earlier studies re-
ported lower rates of MRSA resistance to mupirocin.
For instance, studies on burn patients in England, India,
and Iran reported that this rate was 5.1, 22.7, and 34%,
respectively [31, 38, 39]. The use of mupirocin for treat-
ing burn wound infections caused by S. aureus might
have caused resistance to mupirocin among MRSA iso-
lates. Previous studies in the setting of the present study
showed Pseudomonas aeruginosa as one the main causes
of burn wound infection in recent years [40, 41]. Of
course, there are no detailed data about the use of
mupirocin in the study setting. However, a study re-
ported a substantially high prevalence of mupirocin-re-
sistant MRSA among patients previously treated with
mupirocin. Similarly, a high likelihood of mupirocin re-
sistance was observed among patients with Pseudomonas
infection treated with cefepime [42]. Mupirocin is pro-
duced by the Gram-negative bacterium Pseudomonas
fluorescens and hence, Pseudomonas is inherently resist-
ant to mupirocin [43, 44]. Furthermore, the mupA gene,
which mediates mupirocin resistance in Pseudomonas,
can move between bacterial isolates and thereby, cause
mupirocin resistance in other isolates such as MRSA
[45–47].
Our results also indicated dt10di, dt8 h, and dt8i as
the most prevalent dru types in MRSA with SCCmec
type IIIA (Fig. 1). The dru type dt10di (i.e. cluster I) was
mostly prevalent in the first nine months of the study,
while the dru types dt8 h and dt8i (i.e. cluster II) were
mostly prevalent in the last trimester. These findings
may be due to the fact that the dru types dt8 h and dt8i
might have been entered to the study setting in the last
trimester or might have been emerged as a result of the
polymorphism of dt10ao dru type. Unlike our results, a
study in Malaysia reported nine dru types in SCCmec
type III, the most prevalent of which was the dt13d dru
type (41%) [17]. Moreover, a study in Scotland detected
25 dru types and 33 dru repeats, with the dt10a and
dt7c as the most prevalent dru types, respectively [16].
The greater number of dru types and dru repeats in that
study compared to our study can be due to the fact that
samples in the present study were selected from a single
hospital, while samples in that study were selected from
different hospitals.
The results of the present study also indicated the
higher prevalence of cluster II in the last three months
of the study. This may denote the increasing prevalence
of this cluster. Moreover, compared with cluster I, clus-
ter II had higher resistance to rifampin. Besides, the
presence of the hlb gene was more prevalent in cluster
II. The most prevalent antimicrobial resistance pattern
in cluster I was erythromycin+clindamycin+cotrimoxa-
zole+mupirocin, while the most prevalent antimicrobial
resistance pattern in cluster II was erythromycin+clinda-
mycin+cotrimoxazole+rifampin+mupirocin. The latter
finding confirms the higher resistance to rifampin in
cluster II. Of course, the number of samples in cluster II
was small and hence, further studies with larger samples
are recommended.
Virulence gene patterns in clusters and dru types in
the present study showed that the most prevalent viru-
lence gene patterns in cluster I were hla + sea (39%) and
sea (12%), while the most prevalent virulence gene pat-
tern in cluster II was hla + hlb (33.3%) (Data were not
presented). Besides, hla + hlb virulence genes in the dt8i
dru type were more prevalent than the other dru types.
Considering the significant roles of these genes in ex-
acerbating skin infections, the prevalence of these strains
can complicate the conditions of patients with burn
wound infections. Of course, because of the small sam-
ple size in cluster II, drawing definitive conclusions in
this area is impossible.
Conclusion
This study shows the high prevalence of SCCmec IIIA
among MRSA strains isolated from burn wounds in a
teaching hospital in Tehran, Iran. These strains are
highly resistant to multiple antibiotics. The three most
common dru types among these strains are dt10i, dt8 h,
and dt8i. Clusters with these dru types significantly differ
from each other respecting their antimicrobial resistance
patterns.
Abbreviations
ATCC: American Type Culture Collection; bp: base pair; CD: Clindamycin;
CLSI: Clinical and Laboratory Standards Institute; DAD: Disk Agar Diffusion;
dru: direct repeat unit; dt: dru type; E: Erythromycin; eta: exfoliative toxin A;
LZD: Linezolid; MIC: Minimum Inhibitory Concentration; MRSA: Methicillin-
Resistant Staphylococcus aureus; MST: Minimum Spanning Tree;
MUP: Mupirocin; PCR: Polymerase Chain Reaction; pvl: Panton–Valentine
leukocidin; RP: Rifampicin; S. aureus: Staphylococcus aureus;
SCCmec: Staphylococcal Cassette Chromosome mec; SYN: quinupristin/
dalfopristin; TS: trimethoprim/ Sulfamethoxazole; tst: toxic shock syndrome
toxin; VRSA: Vancomycin-Resistant Staphylococcus aureus
Acknowledgements
We would like to thank Ms. Mahboobeh Sattarzadeh-Tabrizi, who assisted us
with specimen collection. This research has been supported by Tehran Uni-
versity of Medical Sciences & health Services grant 97-01-30/38035.
Funding
This research has been supported by Tehran University of Medical Sciences &
health Services (grant code: 97–01-30/38035).
Availability of data and materials
Please contact author for data requests.
Authors’ contributions
ME and FJ designed the study. MM and ME drafted the manuscript. RB
performed data analysis. All authors provided intellectual input to the study
and read and approved the final manuscript.
Motallebi et al. Antimicrobial Resistance and Infection Control            (2019) 8:50 Page 6 of 8
Ethics approval and consent to participate
This study has the formal approval of the Research Ethics Committee of





The authors declare no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Infectious Diseases Research Center, Kashan University of Medical Sciences,
Kashan, Iran. 2Department of Immunology and Microbiology, Faculty of
Medicine, Kashan University of Medical Sciences, Kashan, Iran. 3Department
of Microbiology, School of Medicine, Tehran University of Medical Sciences,
Building No. 7, 100 Poursina St., Keshavarz Blvd., Tehran 14167-53955, Iran.
Received: 6 August 2018 Accepted: 24 February 2019
References
1. Emaneini M, Beigverdi R, van Leeuwen WB, Rahdar H, Karami-Zarandi M,
Hosseinkhani F, et al. Prevalence of methicillin-resistant Staphylococcus
aureus isolated from burn patients in Iran: a systematic review and meta-
analysis. J Glob Antimicrob Resist Netherlands. 2018 Mar;12:202–6.
2. Rodrigues MVP, Fortaleza CMCB, Riboli DFM, Rocha RS, Rocha C, da Cunha
M de LR de S. Molecular epidemiology of methicillin-resistant
Staphylococcus aureus in a burn unit from Brazil. Burns. Netherlands; 2013
Sep;39(6):1242–1249.
3. Toscano Olivo TE, de Melo EC, Rocha C, Fortaleza CMCB. Risk factors for
acquisition of methicillin-resistant Staphylococcus aureus among patients
from a burn unit in Brazil. Burns. Netherlands. 2009 Dec;35(8):1104–11.
4. Motallebi M, Jabalameli F, Asadollahi K, Taherikalani M, Emaneini M.
Spreading of genes encoding enterotoxins, haemolysins, adhesin and
biofilm among methicillin resistant Staphylococcus aureus strains with
staphylococcal cassette chromosome mec type IIIA isolated from burn
patients. Microb Pathog. England. 2016 Aug;97:34–7.
5. Shahsavan S, Emaneini M, Noorazar Khoshgnab B, Khoramian B, Asadollahi
P, Aligholi M, et al. A high prevalence of mupirocin and macrolide
resistance determinant among Staphylococcus aureus strains isolated from
burnt patients. Burns. Netherlands. 2012 May;38(3):378–82.
6. Hosseini SS, Niakan M, Saderi H, Motallebi M, Taherikalani M, Asadollahi K, et
al. Frequency of genes encoding erythromycin ribosomal methylases
among Staphylococcus aureus clinical isolates with different D-phenotypes
in Tehran. Iran Iran J Microbiol Iran. 2016 Jun;8(3):161–7.
7. Hiramatsu K, Ito T, Tsubakishita S, Sasaki T, Takeuchi F, Morimoto Y, et al.
Genomic Basis for Methicillin Resistance in Staphylococcus aureus. Infect
Chemother. Korea (South); 2013 Jun;45(2):117–36.
8. Paterson GK, Harrison EM, Holmes MA. The emergence of mecC methicillin-
resistant Staphylococcus aureus. Trends Microbiol. 2014 Jan;22(1):42–7.
9. Baig S, Johannesen T, Overballe-Petersen S, Larsen J, Larsen AR, Stegger M.
Novel SCC mec type XIII (9A) identified in an ST152 methicillin-resistant
Staphylococcus aureus. Infect Genet Evol. 2018 Mar;1:61.
10. Asghar AH. Molecular characterization of methicillin-resistant Staphylococcus
aureus isolated from tertiary care hospitals. Pakistan J Med Sci Pakistan. 2014
Jul;30(4):698–702.
11. Chongtrakool P, Ito T, Ma XX, Kondo Y, Trakulsomboon S, Tiensasitorn C, et
al. Staphylococcal cassette chromosome mec (SCCmec) typing of
methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian
countries: a proposal for a new nomenclature for SCCmec elements.
Antimicrob Agents Chemother. United States. 2006 Mar;50(3):1001–12.
12. Fuchs PC, Kopp J, Hafner H, Kleiner U, Pallua N. MRSA-retrospective analysis
of an outbreak in the burn Centre Aachen. Burns. Netherlands. 2002 Sep;
28(6):575–8.
13. Namvar AE, Afshar M, Asghari B, Rastegar LA. Characterisation of SCCmec
elements in methicillin-resistant Staphylococcus aureus isolated from burn
patients. Burns. Netherlands. 2014 Jun;40(4):708–12.
14. Parhizgari N, Khoramrooz SS, Malek Hosseini SAA, Marashifard M,
Yazdanpanah M, Emaneini M, et al. High frequency of multidrug-resistant
Staphylococcus aureus with SCCmec type III and Spa types t037 and t631
isolated from burn patients in southwest of Iran. APMIS Denmark. 2016 Mar;
124(3):221–8.
15. Ryffel C, Bucher R, Kayser FH, Berger-Bachi B. The Staphylococcus aureus mec
determinant comprises an unusual cluster of direct repeats and codes for a
gene product similar to the Escherichia coli sn-glycerophosphoryl diester
phosphodiesterase. J Bacteriol United States. 1991 Dec;173(23):7416–22.
16. Goering RV, Morrison D, Al-Doori Z, Edwards GFS, Gemmell CG. Usefulness
of mec-associated direct repeat unit (dru) typing in the epidemiological
analysis of highly clonal methicillin-resistant Staphylococcus aureus in
Scotland. Clin Microbiol Infect England. 2008 Oct;14(10):964–9.
17. Ghaznavi-Rad E, Goering RV, Nor Shamsudin M, Weng PL, Sekawi Z, Tavakol
M, et al. Mec-associated dru typing in the epidemiological analysis of ST239
MRSA in Malaysia. Eur J Clin Microbiol infect dis. Germany. 2011 Nov;30(11):
1365–9.
18. Bartels MD, Boye K, Oliveira DC, Worning P, Goering R, Westh H.
Associations between dru types and SCCmec cassettes. PLoS One United
States. 2013;8(4):e61860.
19. Connie R. Mahon, Donald C. Lehman GMJ. Textbook of Diagnostic
Microbiology. 5th Edition. Saunders; 2014.
20. Fatholahzadeh B, Emaneini M, Gilbert G, Udo E, Aligholi M, Modarressi MH,
et al. Staphylococcal cassette chromosome mec (SCCmec) analysis and
antimicrobial susceptibility patterns of methicillin-resistant Staphylococcus
aureus (MRSA) isolates in Tehran. Iran Microb Drug Resist United States.
2008 Sep;14(3):217–20.
21. Soroush S, Jabalameli F, Taherikalani M, Amirmozafari N, Fooladi AAI,
Asadollahi K, et al. Investigation of biofilm formation ability, antimicrobial
resistance and the staphylococcal cassette chromosome mec patterns of
methicillin resistant Staphylococcus epidermidis with different sequence
types isolated from children. Microb Pathog. England. 2016 Apr;93:126–30.
22. Emaneini M, Jabalameli L, Iman-Eini H, Aligholi M, Ghasemi A, Nakhjavani
FA, et al. Multiple-locus variable number of tandem repeats fingerprinting
(MLVF) and virulence factor analysis of methicillin resistant Staphylococcus
aureus SCCmec type III. Polish J Microbiol Poland. 2011;60(4):303–7.
23. Clinical and Laboratory Standards Institute (CLSI).Available online: https://clsi.
org/standards/products/microbiology/ (accessed on 10 September 2017).
2017.
24. Emaneini M, Bigverdi R, Kalantar D, Soroush S, Jabalameli F, Noorazar
Khoshgnab B, et al. Distribution of genes encoding tetracycline resistance
and aminoglycoside modifying enzymes in Staphylococcus aureus strains
isolated from a burn center. Ann Burns Fire Disasters Italy. 2013 Jun;26(2):
76–80.
25. Ito T, Kuwahara-Arai K, Katayama Y, Uehara Y, Han X, Kondo Y, et al.
Staphylococcal cassette chromosome mec (SCCmec) analysis of MRSA.
Methods Mol Biol United States. 2014;1085:131–48.
26. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, et al.
Relationships between Staphylococcus aureus genetic background, virulence
factors, agr groups (alleles), and human disease. Infect Immun United States.
2002 Feb;70(2):631–41.
27. Mehrotra M, Wang G, Johnson WM. Multiplex PCR for detection of genes
for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock
syndrome toxin 1, and methicillin resistance. J Clin Microbiol. United States.
2000 Mar;38(3):1032–5.
28. Nishi J, Miyanohara H, Nakajima T, Kitajima I, Yoshinaga M, Maruyama I, et
al. Molecular typing of the methicillin resistance determinant (mec) of
clinical strains of Staphylococcus based on mec hypervariable region length
polymorphisms. J Lab Clin Med United States. 1995 Jul;126(1):29–35.
29. Hoseini Alfatemi SM, Motamedifar M, Hadi N, Sedigh Ebrahim Saraie H.
Analysis of Virulence Genes Among Methicillin Resistant Staphylococcus
aureus (MRSA) Strains. Jundishapur J Microbiol. Iran; 2014 Jun;7(6):e10741.
30. Askari E, Soleymani F, Arianpoor A, Tabatabai SM, Amini A, Naderinasab M.
Epidemiology of mecA-methicillin resistant Staphylococcus aureus (MRSA) in
Iran: a systematic review and meta-analysis. Iran J Basic Med Sci. 2012;15(5):
1010–9.
31. Abbasi-Montazeri E, Khosravi AD, Feizabadi MM, Goodarzi H, Khoramrooz SS,
Mirzaii M, et al. The prevalence of methicillin resistant Staphylococcus aureus
Motallebi et al. Antimicrobial Resistance and Infection Control            (2019) 8:50 Page 7 of 8
(MRSA) isolates with high-level mupirocin resistance from patients and
personnel in a burn center. Burns Netherlands. 2013 Jun;39(4):650–4.
32. Guggenheim M, Zbinden R, Handschin AE, Gohritz A, Altintas MA, Giovanoli P.
Changes in bacterial isolates from burn wounds and their antibiograms: a 20-year
study (1986-2005). Burns. Netherlands. 2009 Jun;35(4):553–60.
33. Hodle AE, Richter KP, Thompson RM. Infection control practices in U.S. burn
units. J burn care res. England. 2006;27(2):142–51.
34. Nimmo GR, Pearson JC, Collignon PJ, Christiansen KJ, Coombs GW, Bell JM,
et al. Antimicrobial susceptibility of Staphylococcus aureus isolated from
hospital inpatients, 2009: report from the Australian group on antimicrobial
resistance. Commun Dis Intell Q Rep Australia. 2011 Sep;35(3):237–43.
35. Aires de Sousa M, Crisostomo MI, Sanches IS, Wu JS, Fuzhong J, Tomasz A,
et al. Frequent recovery of a single clonal type of multidrug-resistant
Staphylococcus aureus from patients in two hospitals in Taiwan and China. J
Clin Microbiol. United States; 2003 Jan;41(1):159–63.
36. Arakere G, Nadig S, Swedberg G, Macaden R, Amarnath SK, Raghunath D.
Genotyping of methicillin-resistant Staphylococcus aureus strains from two
hospitals in Bangalore, South India. J Clin Microbiol United States. 2005 Jul;
43(7):3198–202.
37. Cirlan M, Saad M, Coman G, Bilal NE, Elbashier AM, Kreft D, et al.
International spread of major clones of methicillin resistant Staphylococcus
aureus: nosocomial endemicity of multi locus sequence type 239 in Saudi
Arabia and Romania. Infect Genet Evol Netherlands. 2005 Oct;5(4):335–9.
38. Krishnan PU, Miles K, Shetty N. Detection of methicillin and mupirocin
resistance in Staphylococcus aureus isolates using conventional and
molecular methods: a descriptive study from a burns unit with high
prevalence of MRSA. J Clin Pathol England. 2002 Oct;55(10):745–8.
39. Rudresh MS, Ravi GS, Motagi A, Alex AM, Sandhya P, Navaneeth BV. Prevalence
of mupirocin resistance among staphylococci, its clinical significance and
relationship to clinical use. J Lab Physicians India. 2015;7(2):103–7.
40. Heidari H, Emaneini M, Dabiri H, Jabalameli F. Virulence factors, antimicrobial
resistance pattern and molecular analysis of Enterococcal strains isolated from
burn patients. Microb Pathog England. 2016 Jan;90:93–7.
41. Salimi F, Eftekhar F. Prevalence of blaIMP, and blaVIM gene carriage in
metallo-beta-lactamase-producing burn isolates of Pseudomonas
aeruginosa in Tehran. Turkish J Med Sci Turkey. 2014;44(3):511–4.
42. Caffrey AR, Quilliam BJ, LaPlante KL. Risk factors associated with mupirocin
resistance in meticillin-resistant Staphylococcus aureus. J Hosp Infect
England. 2010 Nov;76(3):206–10.
43. Yanagisawa T, Kawakami M. How does Pseudomonas fluorescens avoid
suicide from its antibiotic pseudomonic acid?: evidence for two
evolutionarily distinct isoleucyl-tRNA synthetases conferring self-defense. J
Biol Chem United States. 2003 Jul;278(28):25887–94.
44. Sutherland R, Boon RJ, Griffin KE, Masters PJ, Slocombe B, White AR.
Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for
topical use. Antimicrob Agents Chemother. United States. 1985 Apr;27(4):
495–8.
45. Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin resistance. Clin Infect Dis United
States. 2009 Sep;49(6):935–41.
46. Ramsey MA, Bradley SF, Kauffman CA, Morton TM. Identification of
chromosomal location of mupA gene, encoding low-level mupirocin
resistance in staphylococcal isolates. Antimicrob Agents Chemother. United
States. 1996 Dec;40(12):2820–3.
47. Driscoll DG, Young CL, Ochsner UA. Transient loss of high-level mupirocin
resistance in Staphylococcus aureus due to MupA polymorphism. Antimicrob
Agents Chemother United States. 2007 Jun;51(6):2247–8.
Motallebi et al. Antimicrobial Resistance and Infection Control            (2019) 8:50 Page 8 of 8
